title: Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide.
authors.affiliation: Division of Cardiovascular Surgery, Osaka Minami National Hospital, Osaka, Japan. yhayashi@jun.ncvc.go.jp
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Hayashi
authors.forename: Masakatsu
authors.initials: M
authors.lastname: Ohtani
authors.forename: Taizo
authors.initials: T
authors.lastname: Hiraishi
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Kobayashi
mesh_terms: D000284:Administration, Oral; D009320:Atrial Natriuretic Factor / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D002315:Cardiopulmonary Bypass; D005260:Female; D006333:Heart Failure / Q000209:etiology; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000150:complications / Q000601:surgery; D011182:Postoperative Care; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use*; D014262:Tricuspid Valve Insufficiency / Q000150:complications / Q000601:surgery
chemical_list: D013148:Spironolactone; D009320:Atrial Natriuretic Factor